Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A.M.I. develops and manufactures innovative minimally invasive medical devices primarily for surgical applications in coloproctology, urology, and urogynecology. Its products are CE-marked and used worldwide to improve patient outcomes with less pain and faster recovery. No clinical trial data typical of drug development; instead, the company references published studies on device efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on A.M.I. Agency for Medical Innovations.